Last reviewed · How we verify

NCT03487354

Medical Abortion With Single Daily Dose of Misoprostol

Completed Phase 2, PHASE3 Last updated 29 January 2019
What this trial tests

Phase 2, PHASE3 trial testing Misoprostol in Miscarriage in 200 participants. Completed in 10 January 2019.

Timeline
1 April 2018
Primary endpoint
10 January 2019
10 January 2019

Quick facts

Lead sponsorAin Shams University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment200
Start date1 April 2018
Primary completion10 January 2019
Estimated completion10 January 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 40, female only, with Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Medical abortion using multiple vs single daily dose of misoprostol in first trimester miscarriage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Medical methods for first trimester abortion.
    Zhang J, Zhou K, Shan D, Luo X. · · 2022 · cited 19× · PMID 35608608 · DOI 10.1002/14651858.cd002855.pub5

Verify or expand the search:

Other trials of Misoprostol

Trials testing the same drug.

Other recruiting trials for Miscarriage

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487354.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing